Our team of dedicated healthcare professionals at Healthon is ready to assist you
Exploring the landscape of metabolic hormone interventions and how to leverage your area(s) of expertise and passion
It is particularly beneficial for those who: Retatrutide treatment is versatile and can be used to address a variety of health conditions
RELATED: CVS Caremark faces class-action lawsuit over Zepbound, Wegovy coverage The decision prompted a lawsuit filed on behalf of two people who lost Zepbound coverage through their employer-sponsored health care plan, though the lawsuit says some 200,000 people were impacted by Caremarks decision
Our platform, TrimRx, emphasizes the importance of the initial assessment to catch these potential red flags
Retatrutide is not expected to be available before the second half of 2027 at the earliest, and realistically mid-2028 meaning a wait of a year or more from today